RUBCNL: A Potential Drug Target and Biomarker for Proteasome-Mediated Diseases

Target Name: RUBCNL

NCBI ID: G80183

RUBCNL

RUBCNL: A Potential Drug Target and Biomarker for Proteasome-Mediated Diseases

Introduction

Proteasomes are complex protein structures that play a crucial role in regulating various cellular processes. They are involved in the degradation of foreign particles, cellular waste, and damaged proteins, thereby maintaining cellular homeostasis. The protein RUBCNL, also known as protein RUBCNL-like, is a potential drug target and biomarker for several proteasome-mediated diseases. In this article, we will discuss the structure, function, and potential therapeutic applications of RUBCNL.

Structure and Function

RUBCNL is a 21-kDa protein that belongs to the N-endoproteasome (NEP) family. It is expressed in various cell types, including neurons, liver cells, and muscle cells. RUBCNL is composed of a unique N-end region, a transmembrane segment, and a cytoplasmic tail.

The N-end region of RUBCNL is rich in conserved features, including a charged N-terminal residue, a hydrophobic residue, and a negatively charged C-terminal residue. These features are characteristic of proteins that interact with the endoplasmic reticulum (ER) and are involved in the delivery and retention of proteins in the cytosol.

The transmembrane segment of RUBCNL contains a unique 120 amino acid residue that is involved in the formation of a trimeric complex with the N-end region. This segment is known as the N-end-trimeric region (NET) and is critical for the stability and localization of the N-end region.

The cytoplasmic tail of RUBCNL is composed of 115 amino acids and includes a unique GFP-fused protein domain, a leucine-rich repeat (LRR), and a calcineurin-like domain. The GFP-fused protein domain is a common protein-coding region that is involved in the production of intracellular signaling proteins. The LRR is a unique structural feature that is conserved in various evolutionarily distinct protein families, including the RUBCNL family. The calcineurin-like domain is a conserved protein domain that is involved in the regulation of protein-protein interactions and is also found in various signaling pathways.

Function

RUBCNL plays a critical role in the regulation of proteasome-mediated degradation. It is involved in the formation of the N-end-trimeric region, which is responsible for the stability and localization of the N-end region in the ER. The N- The end region of RUBCNL is involved in the formation of a complex with the N-end region of the NEP protein, which promotes the inclusion of RUBCNL in the ER.

In addition to its role in the regulation of proteasome-mediated degradation, RUBCNL is also involved in the regulation of cell apoptosis. It has been shown to be involved in the regulation of cell survival and death, and its expression has been described as being elevated in various types of cancer.

Potential Therapeutic Applications

RUBCNL is a potential drug target for several proteasome-mediated diseases. Its unique structure and function make it an attractive target for small molecules that can modulate its activity.

1. Proteasome-mediated diseases

RUBCNL is involved in the regulation of proteasome-mediated degradation, which is a critical process for the regulation of cellular homeostasis. Alterations in the proteasome system have been implicated in the development of various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

Compounds that can modulate the activity of RUBCNL may have therapeutic applications in these diseases. For example, small molecules that can inhibit the formation of the N-end-trimeric region or modulate the stability of the N-end region may be effective in

Protein Name: Rubicon Like Autophagy Enhancer

Functions: Regulator of autophagy that promotes autophagosome maturation by facilitating the biogenesis of phosphatidylinositol 3-phosphate (PtdIns(3)P) in late steps of autophagy (PubMed:28306502, PubMed:30704899). Acts by antagonizing RUBCN, thereby stimulating phosphatidylinositol 3-kinase activity of the PI3K/PI3KC3 complex (PubMed:28306502). Following anchorage to the autophagosomal SNARE STX17, promotes the recruitment of PI3K/PI3KC3 and HOPS complexes to the autophagosome to regulate the fusion specificity of autophagosomes with late endosomes/lysosomes (PubMed:28306502). Binds phosphoinositides phosphatidylinositol 3-phosphate (PtdIns(3)P), 4-phosphate (PtdIns(4)P) and 5-phosphate (PtdIns(5)P) (PubMed:28306502). In addition to its role in autophagy, acts as a regulator of lipid and glycogen homeostasis (By similarity). May act as a tumor suppressor (Probable)

The "RUBCNL Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RUBCNL comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets